Harry P. Selker

Harry Selker is an American physician and medical researcher at Tufts University School of Medicine, where he serves as Dean of the Clinical and Translational Science Institute and executive director of the Institute for Clinical Research and Health Policy Studies. He is known for creating a class of "predictive instruments" built into electrocardiograph machines that help hospitals triage cardiac patients, and assist physician decision-making.

Early life and education Raised in Seattle, Washington, followed by medical school at Brown University. He later earned a Masters of Science in Public Health at the University of California Los Angeles, where he was a Robert Wood Johnson Foundation Clinical Scholar.

Selker has led a number of studies relating to the glucose-insulin-potassium treatment cocktail known as GIK. In 2012, his IMMEDIATE Trial showed that early administration of GIK made cardiac arrest or death after a heart attack less likely, and reduced the amount of damage to the heart itself by 80%.

Selker is the author of two books: The Affordable Care Act as a National Experiment: Health Policy Innovations and Lessons, and Emergency Diagnostic Tests for Cardiac Ischemia.